In the previous China market webinars earlier this year, we learnt that the Chinese healthcare market is the world’s second largest and one of the most important growth markets for Nordic life science companies. In 2020, China’s total healthcare spending was RMB 7.2 trillion (7.1% of GDP) which is expected to reach RMB 17 trillion by 2030. The same year, China’s medical device market generated a total revenue of RMB 800 billion with annual growth rates of 20% since 2015.
With the release of the overall plan for the Hainan Free Trade Port (FTP) on 1 June 2020 and the latest “Catalogue of Encouraged Industries in Hainan FTP” issued on 27 January 2021, special incentives are granted to “Health services such as high-end professional medical care, rehabilitation and nursing” and the “Application of high-end medical equipment and new medicines”.
To facilitate this, the Hainan Boao Lecheng International Medical Tourism Pilot Zone has been granted preferential policies with the aim to create a world-class international medical destination for advanced medical treatment, rehabilitation, medical R&D, and technology innovation in China.
It is a designated special healthcare zone in China that also offers special fast-track approval procedures that make it easier to register, import, and sell medical devices and medicines in Hainan that are not yet registered in China but approved overseas with a CE mark or FDA license.
To give Nordic life science companies a safe, efficient and easier access to the Chinese healthcare market, this webinar offers you a lot of useful information, and suggestions on a step-by-step process for entering the Hainan Boao Lecheng International Medical Zone.
We will hear presentations from three experts with special knowledge of Hainan Boao Lecheng, the fast-track approval procedures and how to go about entering China through this route.
Who Should Attend?
Medtech and Healthtech companies interested in the Chinese healthcare market that want to learn more and connect with experts who can guide companies through the process, with Hainan Boao Lecheng International Medical Zone as the gateway to the rest of mainland China.
We hope you will join us,
the Swecare team
Agenda:
09:00 – 09:05 Welcome and Introduction
Anna Riby, Regional Director, Swecare
09.05 - 09.15 China’s Healthcare Market
- Overview, Healthy China 2030, Internet+ Healthcare, 14th Five-year Plan
Noam David Stern, Founder, Nordics Management Consulting Co., Ltd. (China-direct.biz)
09.15 - 09.35 Hainan Boao Lecheng International Medical Tourism Pilot Zone
- Preferential Policies and Advantages including fast-track approval procedures
Peter Bootsma, Senior International Officer, Boao Lecheng International Medical Zone
09.35 - 09.50 Fast-track China Entry for Nordic MedTech and WelfareTech Companies
- How to reduce the challenges and time to market via step-by-step process
Peter Ølbye, Partner, Nordic Life Science Platform (NLSP.dk)
09:45 – 10:00 Q&A and summary
